{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:06:40Z","timestamp":1752192400620,"version":"3.41.2"},"reference-count":15,"publisher":"The Endocrine Society","issue":"8","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>A 54-year-old female individual with a history of hyperlipidemia, hypothyroidism, latent autoimmune diabetes of the adult (LADA) with hypoglycemia unawareness, vitiligo, and asthma presented with exercise-limiting pleuritic chest pain and dyspnea. She underwent a full pulmonary and cardiac workup locally and at Mayo Clinic, which were normal and negative for pulmonary embolism and showed no evidence of cardiac ischemia. Her family history and abnormal lipid panels suggested possible familial hypercholesterolemia by Dutch criteria. Lipid fractionation studies were done to further assess abnormal lipid levels and symptoms, as she lives a generally healthy and active lifestyle. Lipid fractionation studies revealed abnormal small, dense (sdLDL) and low-density lipoproteins (LDL) particle numbers. She was started on a triple cholesterol management regimen of ezetimibe, evolocumab, and bempedoic acid, which improved lipid fractionation values and symptoms. This case highlights the utility of using lipid fractionation studies in addition to traditional lipid panels to best treat patients with abnormal lipid panels on lipid-lowering therapy.<\/jats:p>","DOI":"10.1210\/jcemcr\/luaf117","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T15:03:28Z","timestamp":1752159808000},"source":"Crossref","is-referenced-by-count":0,"title":["A Call for Use of Lipid Fractionation Studies in Patients With Abnormal Standard Lipid Profiles"],"prefix":"10.1210","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3084-560X","authenticated-orcid":false,"given":"Megan","family":"Kawamura","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Hawaii John A. Burns School of Medicine , Honolulu, HI 96813 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2833-1744","authenticated-orcid":false,"given":"Isabel","family":"Casimiro","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Hawaii John A. Burns School of Medicine , Honolulu, HI 96813 ,","place":["USA"]},{"name":"Department of Medicine (Endocrinology), Queens University Medical Group , Honolulu, HI 96813 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"issue":"10","key":"2025071011032367100_luaf117-B1","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1210\/jc.2003-030636","article-title":"Low-density lipoprotein size and cardiovascular disease: a reappraisal","volume":"88","author":"Sacks","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2025071011032367100_luaf117-B2","doi-asserted-by":"crossref","first-page":"960522","DOI":"10.3389\/fnume.2022.960522","article-title":"Clinical relevance of nuclear magnetic resonance LipoProfile","volume":"2","author":"Emeasoba","year":"2022","journal-title":"Front Nucl Med"},{"issue":"4","key":"2025071011032367100_luaf117-B3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/MOL.0b013e32833b7756","article-title":"Lipoprotein subfractions and cardiovascular disease risk","volume":"21","author":"Krauss","year":"2010","journal-title":"Curr Opin Lipidol"},{"issue":"8","key":"2025071011032367100_luaf117-B4","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1373\/clinchem.2007.100586","article-title":"Direct determination of lipoprotein particle sizes and concentrations by ion mobility analysis","volume":"54","author":"Caulfield","year":"2008","journal-title":"Clin Chem"},{"issue":"20","key":"2025071011032367100_luaf117-B5","doi-asserted-by":"crossref","first-page":"11962","DOI":"10.1021\/acs.analchem.8b02412","article-title":"Quantitative lipoprotein subclass and low molecular weight metabolite analysis in human Serum and plasma by 1H NMR spectroscopy in a multilaboratory trial","volume":"90","author":"Jim\u00e9nez","year":"2018","journal-title":"Anal Chem"},{"issue":"1","key":"2025071011032367100_luaf117-B6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12944-020-01424-2","article-title":"The extended lipid panel assay: a clinically-deployed high-throughput nuclear magnetic resonance method for the simultaneous measurement of lipids and apolipoprotein B","volume":"19","author":"Garcia","year":"2020","journal-title":"Lipids Health Dis"},{"issue":"11","key":"2025071011032367100_luaf117-B7","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/S0022-2275(20)39710-8","article-title":"Identification and cholesterol quantification of low density lipoprotein subclasses in young adults by VAP-II methodology","volume":"36","author":"Kulkarni","year":"1995","journal-title":"J Lipid Res"},{"issue":"7","key":"2025071011032367100_luaf117-B8","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.3390\/ijms24076669","article-title":"Exploring the association between low-density lipoprotein subfractions and Major adverse cardiovascular outcomes-A comprehensive review","volume":"24","author":"Stanciulescu","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2025071011032367100_luaf117-B9","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamacardio.2019.3780","article-title":"Apolipoprotein B particles and cardiovascular disease: a narrative review","volume":"4","author":"Sniderman","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2025071011032367100_luaf117-B10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2022.04.006","article-title":"Non-genetic influences on lipoprotein(a) concentrations","volume":"349","author":"Enkhmaa","year":"2022","journal-title":"Atherosclerosis"},{"issue":"1","key":"2025071011032367100_luaf117-B11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1186\/s12872-023-03578-0","article-title":"Association of LDL-cholesterol subfractions with cardiovascular disorders: a systematic review","volume":"23","author":"Chary","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"2025071011032367100_luaf117-B12","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3390\/biomedicines11041198","article-title":"Small dense LDL level and LDL\/HDL distribution in acute coronary syndrome patients","volume":"11","author":"Otrante","year":"2023","journal-title":"Biomedicines"},{"issue":"17","key":"2025071011032367100_luaf117-B13","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.jacc.2020.02.059","article-title":"Triglyceride-rich lipoprotein cholesterol, small dense LDL cholesterol, and incident cardiovascular disease","volume":"75","author":"Duran","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2025071011032367100_luaf117-B14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/MOL.0000000000000824","article-title":"Small dense low-density lipoprotein particles: clinically relevant?","volume":"33","author":"Krauss","year":"2022","journal-title":"Curr Opin Lipidol"},{"issue":"2","key":"2025071011032367100_luaf117-B15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/diseases6020045","article-title":"CVD risk stratification in the PCSK9 era: is there a role for LDL subfractions?","volume":"6","author":"Kjellmo","year":"2018","journal-title":"Diseases"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/3\/8\/luaf117\/63723868\/luaf117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/3\/8\/luaf117\/63723868\/luaf117.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T15:03:30Z","timestamp":1752159810000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luaf117\/8196193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,6,13]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luaf117","relation":{},"ISSN":["2755-1520"],"issn-type":[{"value":"2755-1520","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,6,13]]},"article-number":"luaf117"}}